Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) EBT Margin (2020 - 2022)

Historic EBT Margin for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to 2960184.4%.

  • Immuneering's EBT Margin fell 29543967400.0% to 2960184.4% in Q4 2022 from the same period last year, while for Sep 2023 it was 11588326.59%, marking a year-over-year decrease of 115787957500.0%. This contributed to the annual value of 15937.29% for FY2022, which is 143101800.0% down from last year.
  • As of Q4 2022, Immuneering's EBT Margin stood at 2960184.4%, which was down 29543967400.0% from 33781.04% recorded in Q3 2022.
  • In the past 5 years, Immuneering's EBT Margin ranged from a high of 644.49% in Q3 2020 and a low of 2960184.4% during Q4 2022
  • Moreover, its 3-year median value for EBT Margin was 1768.4% (2021), whereas its average is 274998.48%.
  • As far as peak fluctuations go, Immuneering's EBT Margin crashed by -4606200bps in 2021, and later plummeted by 2000000000bps in 2022.
  • Over the past 3 years, Immuneering's EBT Margin (Quarter) stood at 877.48% in 2020, then plummeted by -560bps to 5787.65% in 2021, then crashed by -51047bps to 2960184.4% in 2022.
  • Its EBT Margin stands at 2960184.4% for Q4 2022, versus 33781.04% for Q3 2022 and 12183.19% for Q2 2022.